New insights from SONAR indicate adding sodium glucose co-transporter 2 inhibitors to an endothelin receptor antagonist mitigates fluid retention and enhances albuminuria reduction
Author:
Publisher
Elsevier BV
Subject
Nephrology
Reference15 articles.
1. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy;Perkovic;N Engl J Med,2019
2. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial;Heerspink;Lancet,2019
3. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications;Heerspink;Circulation,2016
4. Endothelin and endothelin antagonists in chronic kidney disease;Kohan;Kidney Int,2014
5. Baseline characteristics and enrichment results from the SONAR trial;Heerspink;Diabetes Obes Metabol,2018
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Treatment of Primary IgA Nephropathy: Change, Change, Change;American Journal of Kidney Diseases;2024-02
2. Treatment and practical considerations of diabetic kidney disease;Frontiers in Medicine;2023-12-01
3. Pathomechanisms of Diabetic Kidney Disease;Journal of Clinical Medicine;2023-11-27
4. Current and future strategies for targeting the endothelin pathway in cardiovascular disease;Nature Cardiovascular Research;2023-11-02
5. Targeting the Endothelin A Receptor in IgA Nephropathy;Kidney International Reports;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3